|
1.
|
Denosumab-Mepha osteo
|
Inj Lös 60 mg/ml
|
Fertigspr 1 Stk
|
174.42
|
206.10
|
01.02.2026
|
|
|
L
|
Nein
|
70066001
|
Mepha Pharma AG
|
Denosumabum
|
22062
|
01.02.2026
|
|
|
|
BioS
|
07.99.
|
M05BX04
|
|
2.
|
Denosumab-Teva onco
|
Inj Lös 120 mg/1.7 ml
|
Durchstf 1.7 ml
|
284.86
|
326.20
|
01.03.2026
|
|
|
L
|
Nein
|
70132001
|
Teva Pharma AG
|
Denosumabum
|
22076
|
01.03.2026
|
|
|
|
BioS
|
07.16.10.
|
M05BX04
|
|
3.
|
Jubbonti
|
Inj Lös 60 mg/ml
|
Fertigspr 1 Stk
|
174.42
|
206.10
|
01.02.2026
|
|
|
L
|
Nein
|
69950001
|
Sandoz Pharmaceuticals AG
|
Denosumabum
|
22001
|
01.02.2026
|
|
|
|
BioS
|
07.99.
|
M05BX04
|
|
4.
|
Osenvelt
|
Inj Lös 120 mg/1.7 ml
|
Durchstf 1.7 ml
|
284.86
|
326.20
|
01.03.2026
|
|
|
L
|
Nein
|
70196001
|
iQone Healthcare Switzerland SA
|
Denosumabum
|
22049
|
01.03.2026
|
|
|
|
BioS
|
07.16.10.
|
M05BX04
|
|
5.
|
Prolia
|
Inj Lös 60 mg/ml m Nadelschutz
|
Fertigspr 1 Stk
|
191.86
|
224.00
|
01.03.2026
|
|
|
L
|
Nein
|
60210001
|
Amgen Switzerland AG
|
Denosumabum
|
19237
|
01.10.2010
|
|
|
|
R
|
07.99.
|
M05BX04
|
|
6.
|
Stoboclo
|
Inj Lös 60 mg/ml
|
Fertigspr 1 Stk
|
174.42
|
206.10
|
01.03.2026
|
|
|
L
|
Nein
|
70199001
|
iQone Healthcare Switzerland SA
|
Denosumabum
|
22048
|
01.03.2026
|
|
|
|
BioS
|
07.99.
|
M05BX04
|
|
7.
|
Wyost
|
Inj Lös 120 mg/1.7ml
|
Durchstf 1.7 ml
|
284.86
|
326.20
|
01.02.2026
|
|
|
L
|
Nein
|
69944001
|
Sandoz Pharmaceuticals AG
|
Denosumabum
|
22000
|
01.02.2026
|
|
|
|
BioS
|
07.16.10.
|
M05BX04
|
|
8.
|
Xgeva
|
Inj Lös 120 mg/1.7 ml Durchstf
|
1.7 ml
|
379.81
|
423.65
|
01.03.2024
|
|
|
L
|
Nein
|
61865001
|
Amgen Switzerland AG
|
Denosumabum
|
19773
|
01.03.2012
|
|
|
|
R
|
07.16.10.
|
M05BX04
|
|
9.
|
Xgeva
|
Inj Lös 120 mg/1 ml Fertspr
|
1 ml
|
379.81
|
423.65
|
01.01.2025
|
|
|
L
|
Nein
|
69520001
|
Amgen Switzerland AG
|
Denosumabum
|
21869
|
01.01.2025
|
|
|
|
R
|
07.16.10.
|
M05BX04
|